These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7994070)

  • 21. The effectiveness of low-dose maintenance i.v. iron therapy: a dialysis facility's experience.
    Peter J; Finkelstein F
    Nephrol Nurs J; 2006; 33(1):71-4, 90. PubMed ID: 16538930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence-based systematic literature review of hemoglobin/hematocrit and all-cause mortality in dialysis patients.
    Volkova N; Arab L
    Am J Kidney Dis; 2006 Jan; 47(1):24-36. PubMed ID: 16377382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving IV iron and anemia management in the hemodialysis setting: a collaborative CQI approach.
    Pruett B; Johnson S; O'Keefe N
    Nephrol Nurs J; 2007; 34(2):206-13. PubMed ID: 17486951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin therapy in pre-dialysis patients with chronic renal failure: lack of need for parenteral iron.
    Trivedi HS; Brooks BJ
    Am J Nephrol; 2003; 23(2):78-85. PubMed ID: 12481145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Stability of hemoglobin levels: an indispensible paradigm change in medical management].
    Zaoui P; Deray G; Ortiz JP; Rostaing L
    Nephrol Ther; 2011 Feb; 7(1 Suppl 2):H5-7. PubMed ID: 21371678
    [No Abstract]   [Full Text] [Related]  

  • 26. Improved response to erythropoietin therapy with long-term continuous iron supplementation.
    Descombes E; Fellay G
    Nephron; 2000 Feb; 84(2):196-7. PubMed ID: 10657727
    [No Abstract]   [Full Text] [Related]  

  • 27. A system for monitoring and dispensing epoetin.
    Cohen MR
    Hosp Pharm; 1990 Aug; 25(8):745-6. PubMed ID: 10105708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adequacy of dialysis and differences in hematocrit among dialysis facilities.
    Ifudu O; Uribarri J; Rajwani I; Vlacich V; Reydel K; Delosreyes G; Friedman EA
    Am J Kidney Dis; 2000 Dec; 36(6):1166-74. PubMed ID: 11096041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing an anemia management protocol. Case study of the anemic patient.
    Hossli S
    ANNA J; 1997 Dec; 24(6):678-84; quiz 685. PubMed ID: 9444110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical factors associated with achieving K/DOQI hemoglobin targets in hemodialysis patients.
    Li S; Foley RN; Gilbertson DT; Liu J; Collins AJ
    Int Urol Nephrol; 2003; 35(3):399-405. PubMed ID: 15160548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anemia management: recognizing opportunities and improving outcomes through nursing interventions.
    Lewis M; Wick GS; Foret J
    Nephrol Nurs J; 2000 Oct; 27(5):507-12. PubMed ID: 16649326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Home dialysis program of the Nashville VA Hospital.
    Latos DL; Spannuth CL; Stone WJ
    South Med J; 1977 Dec; 70(12):1431-5, 1439. PubMed ID: 339360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating levels of thrombopoietin and erythropoietin in hemodialysis patients.
    Otsubo Y; Nitta K; Otsubo S; Kimata N; Miwa N; Watanabe Y; Uchida K; Kawashima A; Yumura W; Akiba T; Nihei H
    Acta Haematol; 2003; 109(4):209-11. PubMed ID: 12853697
    [No Abstract]   [Full Text] [Related]  

  • 34. Implementing continuous quality improvement at the facility level.
    VanValkenburgh DA
    Adv Ren Replace Ther; 2001 Apr; 8(2):104-13. PubMed ID: 11349250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of unit-based continuous quality improvement approach to quality management: applying concepts to practice.
    Fisher A; Rossy D; Butt J; Simpson J
    Can J Nurs Adm; 1995; 8(4):42-58. PubMed ID: 8630322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of intravenous administration of Fe-gluconate-Na complex to maintain adequate body iron stores in hemodialysis patients.
    Navarro JF; Teruel JL; Liaño F; Marcén R; Ortuño J
    Am J Nephrol; 1996; 16(4):268-72. PubMed ID: 8739277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the quality and efficiency of conventional in-center hemodialysis.
    Hingwala J; Tangri N; Rigatto C; Komenda P
    Semin Dial; 2015; 28(2):169-75. PubMed ID: 25752482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current management of anemia in adult hemodialysis patients with end-stage renal disease.
    Frankenfield DL; Johnson CA
    Am J Health Syst Pharm; 2002 Mar; 59(5):429-35. PubMed ID: 11887409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodialysis teaching protocols: an educational tool for both patients and nurses.
    Kollee I; Pearson E
    CANNT J; 2000; 10(2):26-9. PubMed ID: 15712465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous erythropoietin results in lower dose and equivalent hematocrit levels among adult hemodialysis patients: Results from the 1998 End-Stage Renal Disease Core Indicators Project.
    McClellan WM; Frankenfield DL; Wish JB; Rocco MV; Johnson CA; Owen WF;
    Am J Kidney Dis; 2001 May; 37(5):E36. PubMed ID: 11325701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.